A British healthcare design firm has come out with a new drug-delivery device to add to its innovative portfolio: an auto-injector for rheumatoid arthritis patients. On its head, this might not sound ...

Simponi and Simponi Aria (golimumab) can cause mild to serious side effects. A more common side effect includes upper respiratory infection. If side effects from the drug become difficult to tolerate, ...

Centocor Ortho Biotech Inc. and Schering-Plough Corporation has announced that Health Canada has granted approval of Simponi (golimumab) as a once-monthly, subcutaneous therapy for the treatment of ...

Simponi and Simponi Aria (golimumab) are brand-name drugs that’s prescribed for conditions such as psoriatic arthritis (PsA). As with other drugs, Simponi can cause side effects, such as skin rash and ...

Janssen Biotech announced new five-year data from three pivotal Phase 3 studies evaluating Simponi (golimumab) 50mg administered subcutaneously once every four weeks in the treatment of moderately to ...